Skip to main content

Your search for “Patient Equity” returned 217 results

Impact Like None Other

November 7, 2023

When Joan and Irwin Jacobs arrived at UC San Diego in 1966, it was just a fledgling campus, Urey Hall was still under construction and appropriately, “California Dreamin” was the year’s No. 1 top single. Fast-forwarding to 2023, Joan and Irwin’s impact on the campus is immeasurable.

Cancer Treatment of Tomorrow, Today

February 6, 2024

Moores Cancer Center continues to bring state-of-the-art cancer treatments from the bench to the bedside.

Reverse Metabolomics: New Method Finds Biomarker for Inflammatory Bowel Disease

December 5, 2023

UC San Diego scientists’ debut “reverse metabolomics,” a groundbreaking approach to advancing microbiome research. They use the technique to discover hundreds of new human molecules, and a new biomarker and therapeutic target for inflammatory bowel disease

Genetic Testing Cost Effective for Newly Diagnosed GIST

September 28, 2020

UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Blocking Digestive Enzymes May Reverse Shock, Stop Multiorgan Failure

January 23, 2013

New research from the University of California, San Diego published in the Jan. 23 issue of Science Translational Medicine moves researchers closer to understanding and developing treatments for shock, sepsis and multiorgan failure. Collectively, these maladies represent a major unmet medical need: they are the number one cause of mortality…

Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect

September 23, 2020

Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.

Parsing the Genetic Drivers of Head and Neck Cancers

November 17, 2022

UC San Diego researchers expand and deepen understanding of how genetic aberrations fuel human papilloma virus-negative head and neck cancers and, potentially, provide paths to further refinement and improvement of immune checkpoint inhibitors for HPV-negative head and neck cancers.

How a Yeast Cell Helps Crack Open the “Black Box” Behind Artificial Intelligence

March 5, 2018

UC San Diego School of Medicine researchers developed a visible neural network and used it to build DCell, a virtual model of a functioning brewer’s yeast cell. To do this, they amassed all knowledge of cell biology in one place and created a hierarchy of these cellular components. Then they…

Understanding Caste and the Power of Empathy in Human Health

March 3, 2022

…road to health, healing, equity, and social justice starts with a conversation. Conversations like this, and the history and science that they are grounded in, will give us a common language, framing and knowledge to guide our work,” said Dr. Crystal Wiley Cené, chief administrative officer for healthy equity, diversity…

Two Studies Seek to Go Beyond the GIST of Intestinal Tract Cancer

August 24, 2021

UC San Diego researchers identify the mutational drivers for gastrointestinal stroma tumors in the stomach and find a potential drug to treat a subset of GIST tumors afflicting the young.

Category navigation with Social links